GlassScriptPhysician profile
Carol Paradise
NPI 1437447455
$1,629.51
in general payments reported to CMS, 2019-2025
10 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $756 · 2022: $128 · 2023: $229 · 2024: $136 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $852.88 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Janssen Pharmaceuticals, INC | $415.60 | 2021-2024 | Xarelto |
| Medtronic, INC. | $125.55 | 2023 | Endurant Iis |
| 180 Medical, INC. | $50.65 | 2024-2025 | Jobst Relief, Medi |
| Misonix INC | $48.35 | 2021 | |
| Organogenesis INC. | $44.48 | 2024-2025 | Puraply Wound Matrix |
| Boston Scientific Corporation | $34.92 | 2025 | Enroute Transcarotid Stent |
| Terumo Medical Corporation | $23.12 | 2024 | Azur Cx Detachable |
| Angiodynamics, INC. | $22.20 | 2025 | Auryon Laser System 100-120 Vac |
| Olympus America INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Paradise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.